NSE:PGHL

Procter & Gamble Health Limited · NSE · Healthcare · INR · FY for 2026

Figures on this page computed 2026-11-08 13:23 UTC

Last close

n/aINR

Market data

28.2xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
INR
- computed
- Computed from the filing for 2026
90.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
23.2%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
22.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.02Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
3.7%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
INR
- computed

Price is the furthest below its sector's middle: 0.22 against 0.36 on the market's range.

Follow one rupee

lens 1 of 9

After what it costs to make

56.6%

After running the business

30.8%

After interest and tax

23.2%

After what it must reinvest

22.9%

Kept after the dividend

-1.3%

after what it costs to make, 56.6% of sales; after running the business, 30.8% of sales; after interest and tax, 23.2% of sales; after what it must reinvest, 22.9% of sales; kept after the dividend, -1.3% of sales

The five stops

5 of 5 read

After what it costs to make7,967,400,00056.6%
After running the business4,330,700,00030.8%
After interest and tax3,269,100,00023.2%
After what it must reinvest3,222,800,00022.9%
Kept after the dividend-180,000,000-1.3%

Of every unit of sales, -0.01 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales14,079,700,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
After what it costs to make7,967,400,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
After running the business4,330,700,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
After interest and tax3,269,100,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
After what it must reinvest3,222,800,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR
Kept after the dividend-180,000,000
Source
computed
Statement
income
Fiscal year
2026
Reported in
INR